ACM
HRTX icon

Anfield Capital Management’s Heron Therapeutics HRTX Stock Holding History

Anfield Capital Management’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$62.1K Sell
30,000
-111,185
-79% -$230K 0.02% 147
2025
Q1 		$311K Buy
141,185
+22,209
+19% +$48.9K 0.11% 58
2024
Q4 		$182K Buy
118,976
+6,264
+6% +$9.58K 0.07% 73
2024
Q3 		$224K Buy
+112,712
New +$224K 0.09% 65